abstract |
The invention relates to the use of heparanase inhibitors for the treatment of heart failure, especially congestive heart failure, and related indications, symptoms and/or dysfunctions such as peripheral edema, pulmonary and liver congestion, dyspnea, hydrothorax and abdominal dropsy. The invention also relates to a method for producing pharmaceutical agents used to treat heart failure. |